

NCT03223909 Raw comparison:

Summary:
CHIA has 33 criteria while your personal folder has 38 criteria
Total found criteria: 33/33
Total not Found: 0/33
Total Extra: 5
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ >18 to < 90 years old                              │ \>18 to \< 90 years old                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Both sexes                                         │ Both sexes                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Mild to moderate tear film dysfunction clinical    │ Mild to moderate tear film dysfunction clinical    │
│ diagnose                                           │ diagnose                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ TBUT > 5 sec and < 10 sec                          │ TBUT \> 5 sec and \< 10 sec                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Schirmer > 4 mm and < 14 mm                        │ Schirmer \> 4 mm and \< 14 mm                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ OSDI < 30 points                                   │ OSDI \< 30 points                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Corneal staining < grade III on the Oxford scale   │ Corneal staining \< grade III on the Oxford scale  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Availability to go to each revision when indicated │ Availability to go to each revision when indicated │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects with topical and/or systemic medication   │ Subjects with topical and/or systemic medication   │
│ or mechanical devices that interfere determinedly  │ or mechanical devices that interfere determinedly  │
│ on the results of the study (such as topical       │ on the results of the study (such as topical       │
│ immunomodulators punctal plugs corticosteroids     │ immunomodulators punctal plugs corticosteroids     │
│ preservative artificial tears contact lenses)      │ preservative artificial tears contact lenses)      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects (females) with active sexual life that do │ Subjects (females) with active sexual life that do │
│ not use a contraceptive method                     │ not use a contraceptive method                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Female subjects who are pregnant or lactating      │ Female subjects who are pregnant or lactating      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Female subjects with a positive urine pregnancy    │ Female subjects with a positive urine pregnancy    │
│ test                                               │ test                                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Positive drug addictions* (verbal interrogatory)   │ Positive drug addictions\* (verbal interrogatory)  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects who have participated on any other        │ Subjects who have participated on any other        │
│ research clinical trials on the last 40 days       │ research clinical trials on the last 40 days       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects legal or mentally disabled to give an     │ Subjects legal or mentally disabled to give an     │
│ informed consent for participating on this study   │ informed consent for participating on this study   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects who can't comply with the appointments or │ Subjects who can't comply with the appointments or │
│ with every protocol requirement                    │ with every protocol requirement                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Serious tear film dysfunction syndrome TBUT < 5 s  │ Serious tear film dysfunction syndrome TBUT \< 5 s │
│ Schirmer < 4 mm OSDI > 30 pints Corneal staining > │ Schirmer \< 4 mm OSDI \> 30 pints Corneal staining │
│ grade III on the Oxford scale                      │ \> grade III on the Oxford scale                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Non perforated corneal ulcer                       │ Non perforated corneal ulcer                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Perforated corneal ulcer                           │ Perforated corneal ulcer                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Autoimmune corneal ulcer                           │ Autoimmune corneal ulcer                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ocular surface scarring diseases                   │ Ocular surface scarring diseases                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ocular surface or annexes metaplastic lesions      │ Ocular surface or annexes metaplastic lesions      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Fibro vascular proliferation lesions on the        │ Fibro vascular proliferation lesions on the        │
│ conjunctival and/or corneal surface (i e           │ conjunctival and/or corneal surface (i e           │
│ pterygium)                                         │ pterygium)                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Concomitant chronic inflammatory diseases on any   │ Concomitant chronic inflammatory diseases on any   │
│ ocular structure                                   │ ocular structure                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute or infectious inflammatory disease           │ Acute or infectious inflammatory disease           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Corneal disease potentially requiring a treatment  │ Corneal disease potentially requiring a treatment  │
│ during the following 3 months                      │ during the following 3 months                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Use of topical or systemic drug products           │ Use of topical or systemic drug products           │
│ classified as forbidden                            │ classified as forbidden                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ocular surgical procedures 3 months before the     │ Ocular surgical procedures 3 months before the     │
│ protocol inclusion                                 │ protocol inclusion                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Treatments or procedures indicated on the tear     │ Treatments or procedures indicated on the tear     │
│ film dysfunction treatment as punctal silicone     │ film dysfunction treatment as punctal silicone     │
│ plugs                                              │ plugs                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Posterior segment diseases requiring a treatment   │ Posterior segment diseases requiring a treatment   │
│ or threatening the visual prognosis                │ or threatening the visual prognosis                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Retinal diseases potentially requiring treatment   │ Retinal diseases potentially requiring treatment   │
│ during the following 3 months                      │ during the following 3 months                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of penetrating keratoplasty                │ History of penetrating keratoplasty                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Soft or hard contact lenses use during the last    │ Soft or hard contact lenses use during the last    │
│ month from inclusion day                           │ month from inclusion day                           │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒════════════════════════════════════════════════╕
│ Extra Personal Criteria                        │
╞════════════════════════════════════════════════╡
│ Criteria related with ophthalmic ailments      │
├────────────────────────────────────────────────┤
│ General Criteria                               │
├────────────────────────────────────────────────┤
│ Must have maximum age of 80 Years              │
├────────────────────────────────────────────────┤
│ Mild to moderate clinical stage of the disease │
├────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years              │
╘════════════════════════════════════════════════╛